Advanced Search
Users Online: 382
About
About Journal
Editorial Board
Articles
Ahead of Print
Current Issue
Archives
Authors
Submit Article
Instructions
Search
Simple Search
Advanced Search
Image Search
Medline Search
Subscribe
Contact Us
Reader Login
Sign Up
Subscriber Login
Export selected to
Endnote
Reference Manager
Procite
Medlars Format
RefWorks Format
BibTex Format
Access statistics : Table of Contents
2011| January-March | Volume 5 | Issue 1
Online since
December 4, 2017
Archives
Previous Issue
Next Issue
Most popular articles
Most cited articles
Show all abstracts
Show selected abstracts
Export selected to
Viewed
PDF
Cited
ABSTRACTS
XXI Annual conference of indian society of organ transplantation (isot), hyderabad 21st - 23rd october, 2010
January-March 2011, 5(1):9-45
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
1,160
61
-
CASE REPORTS
C5b-9 inhibitor (eculizumab) for antibody-mediated rejection in renal transplantation
Rizwan Hamer, Nithya Krishnan, David Lowe, David Briggs, Daniel Zehnder, Robert Higgins
January-March 2011, 5(1):6-8
Increasingly successful protocols enabling HLA antibody incompatible renal transplantation have resulted in a rise in the incidence of antibody mediated rejection. There are limited options to treat this feared complication. Eculizumab, a potent inhibitor of the complement cascade, has recently been suggested as a possible addition to treatment of AMR. We report the use of eculizumab in three very high risk transplant recipients.
[ABSTRACT]
Full text not available
[PDF]
[Mobile Full text]
[EPub]
502
30
-
ARTICLES
HLA Antibody incompatible transplantation – a mini review
Nithya S Krishnan, Daniel Zehnder, David Briggs, Robert Higgins
January-March 2011, 5(1):1-5
Antibody incompatible transplantation (AiT) is on the rise. This is because of advances in detection of donor specific antibodies, even at very low levels. In spite of this there is an increased risk of acute antibody mediated rejection. There are multiple protocols to prevent and treat antibody mediated rejection. Though they are reasonably successful in reversing acute rejection, graft loss still occurs due to ongoing chronic antibody mediated rejection.
[ABSTRACT]
Full text not available
[PDF]
[Mobile Full text]
[EPub]
469
60
-
© Indian Journal of Transplantation | Published by Wolters Kluwer -
Medknow
Sitemap
|
What's New
|
Feedback
|
Disclaimer
|
Privacy Notice
|
FAQ
Online since 9
th
June,2017
